Dai-Dan Co., Ltd.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Dividend History 3Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥64 | +93.0% |
| 2024 | ¥33 | +81.8% |
| 2023 | ¥18 | +22.2% |
| 2022 | ¥15 | 0.0% |
| 2021 | ¥15 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥162,929M | ¥185,961M | ¥197,431M | ¥262,732M |
| Gross Profit | ¥20,723M | ¥22,624M | ¥26,218M | ¥41,350M |
| Operating Income | ¥7,585M | ¥8,429M | ¥10,878M | ¥23,038M |
| Pretax Income | ¥8,410M | ¥9,900M | ¥13,348M | ¥24,203M |
| Net Income | ¥5,778M | ¥6,626M | ¥9,087M | ¥17,443M |
| EPS | ¥45.03 | ¥51.59 | ¥70.70 | ¥135.61 |
| Operating Margin | 4.66% | 4.53% | 5.51% | 8.77% |
| Balance Sheet | ||||
| Total Assets | ¥139,099M | ¥148,544M | ¥160,553M | ¥215,309M |
| Total Equity | ¥77,080M | ¥82,241M | ¥93,754M | ¥107,018M |
| Total Liabilities | ¥62,019M | ¥66,303M | ¥66,799M | ¥108,291M |
| Cash | ¥16,065M | ¥25,379M | ¥22,696M | ¥51,761M |
| Interest-bearing Debt | ¥3,904M | ¥3,621M | ¥3,157M | ¥23,602M |
| Equity Ratio | 55.41% | 55.36% | 58.39% | 49.70% |
| D/E Ratio | 0.05 | 0.04 | 0.03 | 0.22 |
| Cash Flow | ||||
| Operating CF | -¥11,718M | ¥15,941M | ¥596M | ¥12,402M |
| Investing CF | -¥873M | -¥4,729M | -¥603M | -¥832M |
| Financing CF | -¥3,214M | -¥2,218M | -¥2,829M | ¥16,044M |
| Free CF | -¥12,939M | ¥14,132M | -¥1,030M | ¥12,060M |
| Efficiency | ||||
| ROE | 7.50% | 8.06% | 9.69% | 16.30% |
| ROA | 4.15% | 4.46% | 5.66% | 8.10% |
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,667
Rating Score: - (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Dai-Dan Co., Ltd. engages in the design, supervision, and construction of electrical, air conditioning, water hygiene, and firefighting facilities works and machinery in Japan. The company offers Hot Cure, a hospital room for immunocompromised patients; All-in-one CP unit, a cell culture processing facility; air conditioning system for hybrid operating room; MonoBooker, a system which makes the location of temporary equipment visible; brightness design solutions; CV4D, a Construction Visualizer 4D for field survey support; artificial intelligence solutions; REMOVIS, a building monitoring and management solutions; ZEB, which reduces energy consumption in buildings; and Enefice Kyushu, Enefice Shikoku, and Enefice Hokkaido buildings. It also provides iLac system, a breeding rack for experimental animals; Air Barrier Booth, a cross-contamination prevention system; Karatto Operation, air-conditioning system for operating rooms; air purification and negative pressure unit; sputum collection booth; Lami Flowrack system; and Barrier Smart, a room pressure control system. In addition, the company offers WIT WET, vaporization type humidification system; air filter regeneration; airflow analysis solutions; quick covers; lightweight reinforced ducts; heat storage tanks; Virtual Duct Clean Room system; FlowSmart technology; Cushion Ducky, an anti-corrosion technology; and anticorrosion diagnostic technology. Dai-Dan Co., Ltd. was founded in 1903 and is headquartered in Osaka, Japan.